BAT has chosen to seek market authorisation in the US for its heat-not-burn product Glo on the basis of its “substantial equivalence” to a previous product, Eclipse – but what are the pitfalls and the advantages in this approach?
Submit your access request to explore how it streamlines access to critical market and regulatory insights
"*" indicates required fields